The vascular malformations market was valued at USD 2.98 Billion in 2024, driven by the growing advancements in imaging technologies across the 8 major markets. The market is anticipated to grow at a CAGR of 6.50% during the forecast period of 2025-2034, with the values likely to reach USD 5.59 Billion by 2034.
Base Year
Historical Year
Forecast Year
The market is expected to see steady growth due to increasing awareness, advancements in medical technology, and improved diagnostic capabilities, enabling better patient outcomes and treatment options.
Ongoing research into novel therapies, including gene therapy and targeted treatments, is anticipated to significantly boost the market, offering more effective solutions for patients with vascular malformations.
The growing adoption of advanced imaging techniques for early diagnosis and the increasing preference for non-surgical treatment options are expected to drive the vascular malformations market, improving patient management and outcomes.
Vascular malformations are abnormal growths of blood vessels that can occur in various parts of the body, leading to the formation of a network of dilated vessels. These malformations can be present at birth or develop later in life and may cause symptoms like swelling, pain, and bleeding. Treatment options include surgery, sclerotherapy, and laser therapy, depending on the type and location.
Genetic Disorder Research Expands Treatment Options for Vascular Malformations
The increasing focus on precision medicine and the rise in genetic disorder research are key drivers of growth in the vascular malformations market. Advances in genetic research and treatment development for rare conditions, such as vascular malformations, have accelerated over recent years, bringing new treatment options to the forefront. For instance, in July 2024, a study demonstrated the potential of the anticancer drug sotorasib for treating arteriovenous malformations (AVMs) caused by mutations in the KRAS gene. Sotorasib, used for treating non-small cell lung cancer, showed promising effects in preclinical models, preventing the development of vascular malformations. This breakthrough suggests that sotorasib could provide a novel therapeutic avenue for patients with severe AVMs, potentially driving market growth for treatments targeting genetic vascular malformations during the forecast period.
Surge in Advanced Research and Development Initiatives to Boost Vascular Malformations Market Demand
The growing adoption of innovative experimental models and genetic research into vascular disorders is expected to drive significant development in the vascular malformations market. The creation of models that mimic specific vascular malformations enables more accurate preclinical testing and targeted therapies. For instance, in February 2023, a research team from the University of North Carolina developed a microfluidic model that mimics a rare genetic disorder affecting blood and lymphatic vessels. The model focuses on PIK3CA-activating mutations, a gene responsible for various vascular malformations. By providing a more precise model for understanding these rare disorders, the research could pave the way for new treatments targeting PIK3CA-related vascular malformations. This advancement is expected to further stimulate market development, driving demand for more targeted therapies and innovations in the coming years.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Drugs
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Drugs to Witness Significant Growth
The Sirolimus segment is estimated to lead the market share by drugs, due to its proven efficacy in treating complex vascular lesions. Sirolimus, an immunosuppressive drug, helps reduce the size of these malformations and is widely used for conditions like lymphatic malformations. Its ability to effectively manage symptoms and prevent further complications positions it as the most popular choice. The segment’s dominance is further supported by ongoing clinical studies and a growing understanding of its mechanism of action in treating vascular malformations.
The United States dominates the market due to its advanced healthcare infrastructure, high treatment demand, and the presence of key players in the medical device and pharmaceutical sectors. Additionally, the strong adoption of innovative therapies, high healthcare spending, and well-established reimbursement policies contribute to its market leadership. The increasing prevalence of vascular malformations and the availability of advanced diagnostic and therapeutic options further fuel the market's growth in the US during the forecast period.
The key features of the market report comprise patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Headquartered in Lausanne, Switzerland, Galderma Pharma S.A. was established in 1981. Galderma's portfolio specialises in dermatology and includes injectables and devices for reducing wrinkles and other skin concerns.
Founded in 1996 and headquartered in Basel, Switzerland, Novartis AG is a global healthcare company. It offers a broad portfolio of innovative medicines, including treatments for oncology, immunology, ophthalmology, and neuroscience. Novartis is also active in the cardiovascular, dermatology, and respiratory markets, providing a comprehensive range of healthcare solutions.
Bayer AG, established in 1863 and based in Leverkusen, Germany, is a leading global pharmaceutical and life sciences company. Its diverse portfolio includes medications for oncology, cardiology, and women's health, along with dermatology and ophthalmology treatments. Bayer also provides agricultural solutions, veterinary products, and consumer health goods.
Cook Medical LLC, established in 1963 and headquartered in Bloomington, Indiana, USA, is a prominent medical device manufacturer. The company offers a wide range of products for interventional radiology, urology, cardiology, and vascular care. Cook Medical focuses on innovative solutions for minimally invasive procedures across several medical specialities.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Sirtex Medical Limited.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Drugs |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share